|
1
|
World Health Organization (WHO). Review of
the health sector response to HIV and AIDS in Indonesia 2007. WHO,
Regional Office for South-East Asia; pp. 22007, (http://209.61.208.233/catalogue/2005-2011/pdf/aids/review_of_the_health_sector_response_to_HIV_and_AIDS_in_Indonesia.pdfuri).
Accessed December 13, 2012
|
|
2
|
Weber R, Sabin CA, Friis-Moller N, et al:
Liver-related deaths in persons infected with the human
immunodeficiency virus: the D:A:D study. Arch Intern Med.
166:1632–1641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Low E, Vogel M, Rockstroh J and Nelson M:
Acute hepatitis C in HIV-positive individuals. AIDS Rev.
10:245–253. 2008.
|
|
4
|
Sherman KE, Rouster SD, Chung RT and
Rajicic N: Hepatitis C Virus prevalence among patients infected
with human immunodeficiency virus: a cross-sectional analysis of
the US adult AIDS Clinical Trials Group. Clin Infect Dis.
34:831–837. 2002. View
Article : Google Scholar
|
|
5
|
Taylor LE, DeLong AK, Maynard MA, et al:
Acute hepatitis C virus in an HIV clinic: a screening strategy,
risk factors, and perception of risk. AIDS Patient Care STDS.
25:571–577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rockstroh JK and Spengler U: HIV and
hepatitis C virus co-infection. Lancet Infect Dis. 4:437–444. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nelson M, Matthews G, Brook MG and Main J;
BHIVA Coinfection Guideline Committee; British HIV Association.
BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV
and hepatitis C virus infection (2005). HIV Med. 6(Suppl 2):
96–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chamie G, Bonacini M, Bangsberg DR, et al:
Factors associated with seronegative chronic hepatitis C virus
infection in HIV infection. Clin Infect Dis. 44:577–583. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
George SL, Gebhardt J, Klinzman D, et al:
Hepatitis C virus viremia in HIV-infected individuals with negative
HCV antibody tests. J Acquir Immune Defic Syndr. 31:154–162. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Apichartpiyakul C, Chittivudikarn C,
Miyajima H, Homma M and Hotta H: Analysis of hepatitis C virus
isolates among healthy blood donors and drug addicts in Chiang Mai,
Thailand. J Clin Microbiol. 32:2276–2279. 1994.PubMed/NCBI
|
|
11
|
Doi H, Apichartpiyakul C, Ohba KI,
Mizokami M and Hotta H: Hepatitis C virus (HCV) subtype prevalence
in Chiang Mai, Thailand, and identification of novel subtypes of
HCV major type 6. J Clin Microbiol. 34:569–574. 1996.PubMed/NCBI
|
|
12
|
Simmonds P, Bukh J, Combet C, et al:
Consensus proposals for a unified system of nomenclature of
hepatitis C virus genotypes. Hepatology. 42:962–973. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kleter GE, van Doorn LJ, Brouwer JT,
Schalm SW, Heijtink RA and Quint WG: Sequence analysis of the 5′
untranslated region in isolates of at least four genotypes of
hepatitis C virus in The Netherlands. J Clin Microbiol. 32:306–310.
1994.
|
|
14
|
Bruno R, Sacchi P, Puoti M, Soriano V and
Filice G: HCV chronic hepatitis in patients with HIV: clinical
management issues. Am J Gastroenterol. 97:1598–1606. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Camino N, Sheldon J and Soriano V: Update
on hepatitis C treatment in HIV-coinfected patients. Minerva
Gastroenterol Dietol. 50:67–77. 2004.PubMed/NCBI
|
|
16
|
Braitstein P, Yip B, Montessori V, Moore
D, Montaner JS and Hogg RS: Effect of serostatus for hepatitis C
virus on mortality among antiretrovirally naive HIV-positive
patients. CMAJ. 173:160–164. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poles MA and Dieterich DT: Hepatitis C
virus/human immunodeficiency virus coinfection: clinical management
issues. Clin Infect Dis. 31:154–161. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thio CL, Nolt KR, Astemborski J, Vlahov D,
Nelson KE and Thomas DL: Screening for hepatitis C virus in human
immunodeficiency virus-infected individuals. J Clin Microbiol.
38:575–577. 2000.PubMed/NCBI
|
|
19
|
Tor J, Libre JM, Carbonell M, et al:
Sexual transmission of hepatitis C and its relation with hepatitis
B virus and HIV. BMJ. 301:1130–1133. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eyster ME, Alter HJ, Aledort LM, Quan S,
Hatzakis A and Goedert JJ: Heterosexual co-transmission of
hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann
Intern Med. 115:764–768. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mendes-Correa MC, Barone AA and Gianini
RJ: Risk factors associated with hepatitis C among patients
co-infected with human immunodeficiency virus: a case-control
study. Am J Trop Med Hyg. 72:762–767. 2005.PubMed/NCBI
|
|
22
|
Chamot E, Hirschel B, Wintsch J, et al:
Loss of antibodies against hepatitis C virus in HIV-seropositive
intravenous drug users. AIDS. 4:1275–1277. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cribier B, Rey D, Schmitt C, Lang JM, Kirn
A and Stoll-Keller F: High hepatitis C viremia and impaired
antibody response in patients coinfected with HIV. AIDS.
9:1131–1136. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valdez H, Anthony D, Farukhi F, et al:
Immune responses to hepatitis C and non-hepatitis C antigens in
hepatitis C virus infected and HIV-1 coinfected patients. AIDS.
14:2239–2246. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sorbi D, Shen D and Lake-Bakaar G:
Influence of HIV disease on serum anti-HCV antibody titers: a study
of intravenous drug users. J Acquir Immune Defic Syndr Hum
Retrovirol. 13:295–296. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thomson EC, Nastouli E, Main J,
Karayiannis P, Eliahoo J, Muir D and McClure MO: Delayed anti-HCV
antibody response in HIV-positive men acutely infected with HCV.
AIDS. 23:89–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Netski DM, Mosbruger T, Depla E, et al:
Humoral immune response in acute hepatitis C virus infection. Clin
Infect Dis. 41:667–675. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Torriani FJ, Rodriguez-Torres M, Rockstroh
JK, et al; APRICOT Study Group. Peginterferon Alfa-2a plus
ribavirin for chronic hepatitis C virus infection in HIV-infected
patients. N Engl J Med. 351:438–450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gilleece YC, Browne RE, Asboe D, et al:
Transmission of hepatitis C virus among HIV-positive homosexual men
and response to a 24-week course of pegylated interferon and
ribavirin. J Acquir Immune Defic Syndr. 40:41–46. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rockstroh JK, Bhagani S, Benhamou Y, et
al; EACS Executive Committee. European AIDS Clinical Society (EACS)
guidelines for the clinical management and treatment of chronic
hepatitis B and C coinfection in HIV-infected adults. HIV Med.
9:82–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matthews GV and Dore GJ: HIV and hepatitis
C co-infection. Asian Biomed. 3:29–37. 2009.
|
|
32
|
European Association for the Study of the
Liver. EASL Clinical Practice Guidelines: management of hepatitis C
virus infection. J Hepatol. 55:245–264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perez-Olmeda M, Rios P, Nunez M,
Garcia-Samaniego J, Romero M and Soriano V: Virological
characteristics of hepatitis C virus infection in HIV-infected
individuals with chronic hepatitis C: implications for treatment.
AIDS. 16:493–495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung RT, Evans SR, Yang Y, et al: Immune
recovery is associated with persistent rise in hepatitis C virus
RNA, infrequent liver test flares, and is not impaired by hepatitis
C virus in co-infected subjects. AIDS. 16:1915–1923. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chung R: Management of HIV/HCV
coinfection. The PRN Notebook. 9:14–19. 2004.
|
|
36
|
Garten RJ, Zhang J, Lai S, Liu W, Chen J
and Yu XF: Coinfection with HIV and hepatitis C virus among
injection drug users in southern China. Clin Infect Dis.
41:S18–S24. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Filippini P, Coppola N, Scolastico C,
Rossi G, Onofrio M, Sagnelli E and Piccinino F: Does HIV infection
favor the sexual transmission of hepatitis C? Sex Transm Dis.
28:725–729. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tedaldi EM, Hullsiek KH, Malvestutto CD,
et al; Terry Beirn Community Programs for Clinical Research on
AIDS. Prevalence and characteristics of hepatitis C virus
coinfection in a human immunodeficiency virus clinical trials
group: the Terry Beirn Community Programs for Clinical Research on
AIDS. Clin Infect Dis. 36:1313–1317. 2003. View Article : Google Scholar
|
|
39
|
Bollepalli S, Mathieson K, Bay C, Hillier
A, Post J, Van Thiel DH and Nadir A: Prevalence of risk factors for
hepatitis C virus in HIV-infected and HIV/hepatitis C
virus-coinfected patients. Sex Transm Dis. 34:367–370.
2007.PubMed/NCBI
|
|
40
|
Larsen C, Pialoux G, Salmon D, et al:
Prevalence of hepatitis C and hepatitis B infection in the
HIV-infected population of France, 2004. Euro Surveill.
13:1888.82008.PubMed/NCBI
|
|
41
|
Danta M, Brown D, Bhagani S, et al: Recent
epidemic of acute hepatitis C virus in HIV-positive men who have
sex with men linked to high-risk sexual behaviours. AIDS.
21:983–991. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pol S, Thiers V, Nousbaum JB, Legendre C,
Berthelot P, Kreis H and Brechot C: Changing distribution of HCV
genotype in Europe in the last decades. J Hepatol. 21:S131994.
View Article : Google Scholar
|
